Zinc delays the progression of obesity-related glomerulopathy in mice via down-regulating P38 MAPK-mediated inflammation

Obesity

Volumn 24, Issue 6, 2016, Pages 1244-1256

  Luo, Manyu ^a,b   Luo, Ping ^a   Zhang, Zhiguo ^b,c   Payne, Kristen ^b,d   Watson, Sara ^b   Wu, Hao ^a,b   Tan, Yi ^b   Ding, Yushuang ^a   Sun, Weixia ^b,c   Yin, Xinmin ^e   Zhang, Xiang ^e   Liu, Gilbert ^b   Wintergerst, Kupper ^b   Miao, Lining ^a   Cai, Lu ^b  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b University of Louisville School of Medicine   (United States)

^c THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^d MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLOMERULOPATHY; INFLAMMATION; LIPID DIET; MALE; MOUSE; NEPHRITIS; NONHUMAN; OBESITY; SUPPLEMENTATION; ZINC DEFICIENCY;

EID: 84990186562     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21463     Document Type: Article

References (40)

1. Ogden CL, Carroll MD, Kit BK, et al. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014;311:806-814.
2. D'Elia JA, Roshan B, Maski M, et al. Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney. Int J Nephrol Renovasc Dis 2009;2:39-49.
3. Tefft KM, Shaw DH, Ihle SL, et al. Association between excess body weight and urine protein concentration in healthy dogs. Vet Clin Pathol 2014;43:255-260.
4. Wang X, Liu JZ, Hu JX, et al. ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation. Free Radic Biol Med 2011;51:539-551.
5. Li M, Georgakopoulos D, Lu G, et al. p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart. Circulation 2005;111:2494-2502.
6. Wang Y, Huang S, Sah VP, et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 1998;273:2161-2168.
7. Yan Z, Ni Y, Wang P, et al. Peroxisome proliferator-activated receptor delta protects against obesity-related glomerulopathy through the P38 MAPK pathway. Obesity (Silver Spring) 2013;21:538-545.
8. Lee SJ, Kang JG, Ryu OH, et al. Effects of alpha-lipoic acid on transforming growth factor beta1-p38 mitogen-activated protein kinase-fibronectin pathway in diabetic nephropathy. Metabolism 2009;58:616-623.
9. Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003;2:717-726.
10. Shidfar F, Aghasi M, Vafa M, et al. Effects of combination of zinc and vitamin A supplementation on serum fasting blood sugar, insulin, apoprotein B and apoprotein A-I in patients with type I diabetes. Int J Food Sci Nutr 2010;61:182-191.
11. Afkhami-Ardekani M, Karimi M, Mohammadi SM, et al. Effect of zinc sulfate supplementation on lipid and glucose in type 2 diabetic patients. Pak J Nutr 2008;7:550-553.
12. Jayawardena R, Ranasinghe P, Galappatthy P, et al. Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr 2012;4:13
13. Cong W, Zhao T, Zhu Z, et al. Metallothionein prevents cardiac pathological changes in diabetes by modulating nitration and inactivation of cardiac ATP synthase. J Nutr Biochem 2014;25:463-474.
14. Liang T, Zhang Q, Sun W, et al. Zinc treatment prevents type 1 diabetes-induced hepatic oxidative damage, endoplasmic reticulum stress, and cell death, and even prevents possible steatohepatitis in the OVE26 mouse model: Important role of metallothionein. Toxicol Lett 2015;233:114-124.
15. Li B, Cui W, Tan Y, et al. Zinc is essential for the transcription function of Nrf2 in human renal tubule cells in vitro and mouse kidney in vivo under the diabetic condition. J Cell Mol Med 2014;18:895-906.
16. Marreiro DN, Fisberg M, Cozzolino SM. Zinc nutritional status and its relationships with hyperinsulinemia in obese children and adolescents. Biol Trace Elem Res 2004;100:137-149.
17. Tungtrongchitr R, Pongpaew P, Phonrat B, et al. Serum copper, zinc, ceruloplasmin and superoxide dismutase in Thai overweight and obese. J Med Assoc Thai 2003;86:543-551.
18. Isbir T, Tamer L, Taylor A, et al. Zinc, copper and magnesium status in insulin-dependent diabetes. Diabetes Res 1994;26:41-45.
19. Herbein G, Varin A, Fulop T. NF-kappaB, AP-1, Zinc-deficiency and aging. Biogerontology 2006;7:409-419.
20. Zago MP, Mackenzie GG, Adamo AM, et al. Differential modulation of MAP kinases by zinc deficiency in IMR-32 cells: role of H(2)O(2). Antioxid Redox Signal 2005;7:1773-1782.
21. Wang Y, Wang Y, Luo M, et al. Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylation. Biochim Biophys Acta 2015;1852:34-46.
22. Zhang Z, Wang S, Zhou S, et al. Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway. J Mol Cell Cardiol 2014;77:42-52.
23. Lim AK, Nikolic-Paterson DJ, Ma FY, et al. Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice. Diabetologia 2009;52:347-358.
24. Srivastava T. Nondiabetic consequences of obesity on kidney. Pediatr Nephrol 2006;21:463-470.
25. Kawasaki Y, Isome M, Ono A, et al. Two children with obesity-related glomerulopathy identified in a school urinary screening program. Pediatr Int 2014;56:115-118.
26. Fowler SM, Kon V, Ma L, et al. Obesity-related focal and segmental glomerulosclerosis: normalization of proteinuria in an adolescent after bariatric surgery. Pediatr Nephrol 2009;24:851-855.
27. Kaneko K, Kimata T, Tsuji S, et al. Impact of obesity on childhood kidney. Pediatr Rep 2011;3:e27
28. Xu ZG, Lanting L, Vaziri ND, et al. Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney: reversal by angiotensin II type 1 receptor blockade. Circulation 2005;111:1962-1969.
29. Ouchi N, Parker JL, Lugus JJ, et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011;11:85-97.
30. Egger G, Dixon J. Non-nutrient causes of low-grade, systemic inflammation: support for a 'canary in the mineshaft' view of obesity in chronic disease. Obes Rev 2011;12:339-345.
31. El-Atat FA, Stas SN, McFarlane SI, et al. The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 2004;15:2816-2827.
32. Meng Q, Liu H, Wang J. Protective effects of polydatin on HK-2 cells against oxygen-glucose deprivation/re-oxygenation-induced injury by regulating Sonic hedgehog through PI3K/Akt signaling pathway. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2015;31:1452-1457.
33. Decleves AE, Mathew AV, Cunard R, et al. AMPK mediates the initiation of kidney disease induced by a high-fat diet. J Am Soc Nephrol 2011;22:1846-1855.
34. Ghosh SS, Gehr TW, Ghosh S, et al. PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase. Kidney Int 2003;64:52-62.
35. Palomer X, Alvarez-Guardia D, Rodriguez-Calvo R, et al. TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model. Cardiovasc Res 2009;81:703-712.
36. Matoba K, Kawanami D, Tsukamoto M, et al. Rho-kinase regulation of TNF-alpha-induced nuclear translocation of NF-kappaB RelA/p65 and M-CSF expression via p38 MAPK in mesangial cells. Am J Physiol Renal Physiol 2014;307:F571-F580.
37. Adams JL, Badger AM, Kumar S, et al. p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines. Prog Med Chem 2001;38:1-60.
38. Pidduck HG, Wren PJ, Evans DA. Hyperzincuria of diabetes mellitus and possible genetical implications of this observation. Diabetes 1970;19:240-247.
39. Kasai M, Miyazaki T, Takenaka T, et al. Excessive zinc intake increases systemic blood pressure and reduces renal blood flow via kidney angiotensin II in rats. Biol Trace Elem Res 2012;150:285-290.
40. van der Heijden RA, Bijzet J, Meijers WC, et al. Obesity-induced chronic inflammation in high fat diet challenged C57BL/6J mice is associated with acceleration of age-dependent renal amyloidosis. Sci Rep 2015;5:16474